Provider review
Sequence (Weight Watchers Clinic)
Weight Watchers-owned medical weight loss platform combining GLP-1s with coaching.
- 4.00/5 rating
- From $99.00/mo
- 20 states
- 2 GLP-1s
- Accepts insurance
Medically reviewed by Dr. Jane Novak, MD, MPH on May 24, 2026
Awards
Editor's pick
Best Overall 2026
Editor's pick
Cheapest 2026
Editor's pick
Best Rated 2026
Editor's pick
Most Choice 2026
Editor's pick
Best for Insurance 2026
From
$99/mo
Medications
2
States
20
Rating
4.0/5
We earn a commission if you sign up through this link. Editorial ranking is independent.
What we liked
- Integrated behavioral coaching
- Insurance navigation included
- Established brand
What gave us pause
- Subscription required
- Less flexibility than direct competitors
Reader reviews
Verified user experiences. Reviews are moderated before publishing β we strip personal info and reject spam.
No user reviews yet
Be the first to share your experience β consults, shipping, billing, support. The form below takes ~2 minutes.
Ready to try Sequence (Weight Watchers Clinic)?
From $99.00/mo. Commission-funded, editorially independent.
Get started with Sequence (Weight Watchers Clinic) People also ask
Common questions readers ask
- How much does Wegovy cost without insurance?
- List price runs ~$1,350/mo at retail. NovoCare Pharmacy cash-pay direct from Novo Nordisk is $499/mo for all dose strengths. The Wegovy Savings Offer caps copay at $0-$225/mo for commercially insured patients depending on coverage status (not a flat $225 for everyone). Full evidence-graded answer
- Does insurance cover Zepbound?
- Most commercial insurance plans cover Zepbound with prior authorization for adults with BMI β₯30 (or β₯27 + a weight-related comorbidity). Medicare Part D excludes anti-obesity drugs by federal law, so Medicare patients pay cash unless they qualify for Lilly Cares. Full evidence-graded answer
- Is Ozempic the same as Wegovy?
- Same active molecule (semaglutide), different FDA indications and maximum doses. Ozempic = type 2 diabetes, max 2 mg/week. Wegovy = chronic weight management, max 2.4 mg/week. Insurance pathways are very different. Full evidence-graded answer
- Can I still get compounded GLP-1 in 2026?
- For semaglutide: no β FDA declared the shortage resolved February 21, 2025 and 503A compounding is no longer broadly permitted. For tirzepatide: shortage resolved October 2024 (re-affirmed December 2024), with a wind-down enforcement window that ended in 2025. Some clinics still market "compounded" formulations with added ingredients (B12, glycine) as personalized prescriptions; the legal status is contested. Full evidence-graded answer
- How does Wegovy compare to Saxenda?
- Both are GLP-1 agonists from Novo Nordisk. Wegovy (semaglutide, weekly) produces ~15% mean weight loss; Saxenda (liraglutide, daily) produces ~6-8%. Wegovy is also cheaper per kg-lost, more convenient, and has cardiovascular outcome data (SELECT trial). Saxenda was first approved for adolescents (2020); Wegovy followed in 2022 β both are available for ages 12-17. Full evidence-graded answer
Was this page helpful?